Alteration in the activity of transcription factors could be critical for the development and maintenance of radioresistance in breast cancer by control genes of the survival pathways, such as the RAS‐MAPK and TNF pathways (Ishihara et al., 2015; Zhao et al., 2018). Here, TNF is linked to breast carcinoma.